Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy

This publication has 33 references indexed in Scilit:

• Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors
  JNCI Journal of the National Cancer Institute, 1993
• Para‐aortic Lymphadenectomy after Chemotherapy for Metastatic Non‐seminomatous Germ Cell Tumours: Prognostic Value and Therapeutic Benefit
  British Journal of Urology, 1993
• POMBACE chemotherapy in non-seminomatous germ cell tumours: Outcome and importance of dose intensity
  European Journal Of Cancer, 1992
• Two different classes of therapy-related and de-novo acute myeloid leukemia?
  Cancer Genetics and Cytogenetics, 1991
• Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell Tumors
  New England Journal of Medicine, 1990
• Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours
  European Journal of Cancer and Clinical Oncology, 1989
• Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy
  Cancer Chemotherapy and Pharmacology, 1987
• High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumors
  European Journal of Cancer and Clinical Oncology, 1986
• FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITES
  The Lancet, 1983
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958